Device manufacturer, as written on reports
Bd Caribe: medical device reports filed with FDA
1,366 reports name it as the manufacturer of the device involved, 2006–2026.
- 1,366
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 72
- reports, 12 months to August 2026
- 157 in the 12 months before
- 94.1%
- classified as malfunction
- 62.3% across all reports
- 0.1%
- classified as death, as reported
- 0.9% across all reports
1,366 medical device reports received by FDA give Bd Caribe as the manufacturer of the device involved, 0% of the MAUDE database, from June 2006 to July 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
72 reports arrived in the 12 months to August 2026, down 54% from 157 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (94.1%), injury (5.5%) and other (0.3%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| BD Microtainer Tubes with K2E (K2EDTA) | Tubes, vials, systems, serum separators, blood collection | 210 | 43 | 0% |
| BD MiniDraw H&H Capillary Blood Collection Tube | Tubes, vacuum sample, with anticoagulant | 95 | 76 | 0% |
| BD BACTEC Plus Aerobic/F Culture Vials (plastic) | System, blood culturing | 45 | 82 | 0.1% |
| BD BACTEC Lytic/10 Anaerobic/F Culture Vials (plastic) | System, blood culturing | 14 | 99 | 0.1% |
| Bd Bactec Peds Plus / F Culture Vials Plastic | System, blood culturing | 14 | 79 | 0% |
| BD BACTEC Plus Anaerobic/F Culture Vials (plastic) | System, blood culturing | 9 | 99 | 0% |
| Bd Microtainer Contact-Activated Lancet | Single use only blood lancet with an integral sharps injury prevention feature | 1 | 10 | 0% |
| BD Vacutainer K2 EDTA (K2E) 10.8mg Blood Collection Tubes | Tubes, vials, systems, serum separators, blood collection | 1 | 25 | 0% |
| BD Vacutainer Serum Blood Collection Tubes | Tubes, vials, systems, serum separators, blood collection | 1 | 119 | 0% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| JKA | Tubes, vials, systems, serum separators, blood collection | 973 | 71.2% |
| GIM | Tubes, vacuum sample, with anticoagulant | 113 | 8.3% |
| BSP | Needle, conduction, anesthetic (w/wo introducer) | 91 | 6.7% |
| MDB | System, blood culturing | 90 | 6.6% |
| CAZ | Anesthesia conduction kit | 20 | 1.5% |
| FMK | Single use only blood lancet with an integral sharps injury prevention feature | 20 | 1.5% |
| FMI | Needle, hypodermic, single lumen | 8 | 0.6% |
| LFZ | Enzyme linked immunoabsorbent assay, cytomegalovirus | 8 | 0.6% |
| MDM | Instrument, manual, surgical, general use | 4 | 0.3% |
| GKZ | Counter, differential cell | 3 | 0.2% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Bd Caribe reports
How many FDA device reports name Bd Caribe as manufacturer?
1,366 reports through August 2026, 72 of them in the latest 12 months.
Which of its brands appear most often?
BD Microtainer Tubes with K2E (K2EDTA) (210), BD MiniDraw H&H Capillary Blood Collection Tube (95), BD BACTEC Plus Aerobic/F Culture Vials (plastic) (45), BD BACTEC Lytic/10 Anaerobic/F Culture Vials (plastic) (14) and Bd Bactec Peds Plus / F Culture Vials Plastic (14).
Which device types does it report on?
tubes, vials, systems, serum separators, blood collection (71.2%), tubes, vacuum sample, with anticoagulant (8.3%), needle, conduction, anesthetic (w/wo introducer) (6.7%) and system, blood culturing (6.6%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.